Italië - Italiaans - Ministero della Salute

laboratoires boiron srl -

Italië - Italiaans - Ministero della Salute

cemon srl -

Italië - Italiaans - Ministero della Salute

boiron srl -

Italië - Italiaans - AIFA (Agenzia Italiana del Farmaco)

genetic s.p.a. - finasteride - finasteride

Europese Unie - Italiaans - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - neoplasie prostatiche - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Europese Unie - Italiaans - EMA (European Medicines Agency)

accord healthcare s.l.u. - leuprorelin mesilate - neoplasie prostatiche - terapia endocrina - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Italië - Italiaans - AIFA (Agenzia Italiana del Farmaco)

zentiva italia s.r.l. - finasteride - finasteride